ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000574.1|Caulosegnin_1 # 1 # 2445 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000574.1|Caulosegnin_1 	1	2445	+	Loose	1900	28.4906	mexQ	31.03	3003699	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; acridine dye; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGACTTTTCGCAGGGGTGGCGCTGGCTTGCGCGCTCGCCGCGGCGCCGGCTCAGGCCGCCCGTCCCTTCACGATCGAGGACCAGCTTTCGGTCCAGAACTTCGGGCGGGTCGCCTTCTCGCCCGCCGGCCGCTGGCTGATCGCCGAGCGCTATGGGCGCTGGGGCGACGCGCCCAGCTTCGACCACGAGTTCCTGACCCATCAGACCACCAGTCAGATCTTCGTCACCGATCTGCGTGCCAACAGTCCGCCGCGCCCGCTCCTGCCCCAGGCCGCCAAGGCGGGCGACACCTTCGGAGCCTTCTCGCCGGACGGGACACGGGTCTTGGTCTTCCGGCAGGTGGGGCATCGGCGGAAGATGGGCGTGGCCACGCTGGCGACCGGGGCGACGCGATGGTCGGGCCTGACCGCCGATCCCGAGGTGTGGACCGCCCAGGCCCGCTGGCGGGACGATACGCGCGTCGTCGTCATCGCGCGCGCGCCCGACGCCCCGTCGATCCTGCTCGGCGCGGGCTGGCAGACCCAGGCGCGCACCGCGGCGGCCTGGAGCGCCAACAGCCGCGGCGAGGCGTCAGGCGTCGCGCTCGGCGCGGGCCGCTACGCCGGGCTCAATCCGCCGCCGCCCGACTACGACCTGGCGGAATTCGACGCCCACAGCGGCCAGACGCGCGTGCTGGCGCACGGCCCCTTCTTCGAGATCTTGCTGTCGCCCGACGGCCGAACCGTCGCGGCGAGCGAAGAGGGCGAGCTCGTCACGCCCAGCGCCGCGACGGCGATGGTTCGCCTGTCGAGCCCCCATCGCCGTCGGCGCCTGTCCCTCATCGACCTCGACACCGGTGAAATCCGCCGCCCCTGCCCGGCCTGCGATCTTGCCCCGGGGACCTGGGCCTGGTCGCCGGACGGCCAGGCGCTGGTGGCCGCGGCGCGCGATCAGCCGGCGTTCGACGCCGGCTATGGCTACTGGCGGTTCGATCGGCTTGGCGCATCGGTCGCCCTGGCCCCGCGGCTGCGCGTCAATCTCGTCACCGGCGGCGGGATCGCGAACCTGACCGGCCAGGCGGCCTGGCTGGGCGGCGATCCGGTCGTCCTGGCCAAGCCCGAGGGCGCGGCGCGGCCTGACTGGTGGCGCCTCGCGCGCCAGGGCGAAGTCAACCTGACGGCGGCCTTCGCCCCGCCGCAAGGTCGGGCGCTGGCGGTCGGCCCCAAAGGCCTGCTGGTCAATACGGCGGCGGGGCTCGTCCGGCTGCCGCCGAAAGGCCAAGCTCGGGTCATCGCGGCCGGCGCCTGGCAAGGCGCCGGCGCCCTGCCCGGGCTGCCCATAGAGCGCCTCGTCGGAACCGTGGATCATGCCGCGCGGCTGCTGACGCCCGAGGGTCACACCCGGCCGGCCGCCGATCTGCCGAGCCGCGCCCGGCTGGTGGCGACCTCGCCCAGCGGCGATCTCGCGGCCATAGACACCGACGACCATGGGGTCCGCACGCTCAGCCTCTATCGCCCAAACTCGCCGCCGCGCCCGCTGCTGACCATCAACCAGGCCCTTGCCGATGTCGCCTTCAGCCGGCCGGTGGCGATCCCCCACCGTGGGCCAAGCGGCGAGCCTCTGACCAGCTGGCTCTACCTCCCGCCGGGCGGCGCGCTGGGGGACCAGCGCCCGCTGATCATCGTGCCCTATGCCGGCGATCGCTATGATCGGCCGCCCGCCTGGTTCGAGCCGGGCGCGGTCACGCCTCTGACCAATGTCCAGTTGATGGTGGCCCAGGGCTATGCGGTCCTGGTTCCCAGCCTGCCGATCGGCTTGACGGACGAGCCCGCGCCGGGTCTCGCCGCCGCGATCCTGCGGGCGGTCGACGCCGCGCATGTGCAGCATCCCGTCTTCTCGGCCGATCGCCTGGCCGTCTGGGGCCACAGTTTCGGGGGCTGGTCGGCCCTGATGGCCGGCGCGCAATCGCCGCGGTTCAAGGCGCTGATCGCCTCGGCCCCGCCGACCGATCTGATTACCCTGCATGGCAACCTTCGTCTCGCCAGCTTCGCGGTCCCGGAGGTCTATATGACGCTCACCGGGCTGCAGGGCTGGGCCGAGGGCGGCCAGGCCAGGATGGGCGCCCCGCCCTGGAAAGACCTCGATCGGTATGCTCGCAACAGCCCGCTGTTGCAGGTCGACCGGCTCACGGCGCCGGTGATGCTGATCTATGGCGACATGGATTATGACCCAAGCCAGGTCGCGGCCCTGTTCATGGCGCTATCACGACAGGGCAAAGATGCGCAGCTGCTCCTCTATCGCGGCGAGGGCCATGTGATCGGCAATCCGGCCAACCTGCGCGACCTGCATCAACGGGTGTTCGCCTTCCTCGCCGACGTCCTGGGACCGGTCGCCGCCGTCCCGCGCCCCGCGGCCCTCTCGCCCTCGGCGGCTTCCCCCTCGCCGATCCGCGCCTCCCAATGA	MRLFAGVALACALAAAPAQAARPFTIEDQLSVQNFGRVAFSPAGRWLIAERYGRWGDAPSFDHEFLTHQTTSQIFVTDLRANSPPRPLLPQAAKAGDTFGAFSPDGTRVLVFRQVGHRRKMGVATLATGATRWSGLTADPEVWTAQARWRDDTRVVVIARAPDAPSILLGAGWQTQARTAAAWSANSRGEASGVALGAGRYAGLNPPPPDYDLAEFDAHSGQTRVLAHGPFFEILLSPDGRTVAASEEGELVTPSAATAMVRLSSPHRRRRLSLIDLDTGEIRRPCPACDLAPGTWAWSPDGQALVAAARDQPAFDAGYGYWRFDRLGASVALAPRLRVNLVTGGGIANLTGQAAWLGGDPVVLAKPEGAARPDWWRLARQGEVNLTAAFAPPQGRALAVGPKGLLVNTAAGLVRLPPKGQARVIAAGAWQGAGALPGLPIERLVGTVDHAARLLTPEGHTRPAADLPSRARLVATSPSGDLAAIDTDDHGVRTLSLYRPNSPPRPLLTINQALADVAFSRPVAIPHRGPSGEPLTSWLYLPPGGALGDQRPLIIVPYAGDRYDRPPAWFEPGAVTPLTNVQLMVAQGYAVLVPSLPIGLTDEPAPGLAAAILRAVDAAHVQHPVFSADRLAVWGHSFGGWSALMAGAQSPRFKALIASAPPTDLITLHGNLRLASFAVPEVYMTLTGLQGWAEGGQARMGAPPWKDLDRYARNSPLLQVDRLTAPVMLIYGDMDYDPSQVAALFMALSRQGKDAQLLLYRGEGHVIGNPANLRDLHQRVFAFLADVLGPVAAVPRPAALSPSAASPSPIRASQ	MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP	77.30	gnl|BL_ORD_ID|2053|hsp_num:0	2212		
BGC0000574.1|Caulosegnin_2 # 2331 # 4184 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0000574.1|Caulosegnin_2 	2331	4184	-	Loose	500	28.8758	OXA-3	36.59	3001398	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGCTACGCGGCCTTGACCTATCCGGGCGGTCTGGCCGCCGCCGCGTTCGACGAGATGGTCGAGGCGCTGATCGACGCCGGCTGGACCCTGGCGCTGCGGGCGTTTCGGCTGGCGGTCCTGACCGATGGCCAGGCGCCGGCCGTTTCGCCGCTGATGGGACGGGGCGGCGTGGCGGGGGTGTTGATCGGTGAAGCCTTTGACCGACGGGCGACCCTGGGCGGCGCGGTCGCGCGCGCGGCGCTCGACGGTCTTGCCGACATCGATCCGCTCGAGGCCGGTCGTCACCTGATCGAGACCGCTTGGGGCGGCTATGTCGGGATGTGGATCGGTCGCGCCGAAGCGGGGCCAACCTTGCTGCGCGATCCGTCAGGGGCCCTGGAGGCGCTGGCCTGGCGGCGCGACGGCGTCACGGTGATGAGCGCTCGTCCGCTCACCGGTCGCGCCGGTCCGGCGGACTTGGCGATCGACTGGCCGCGGATCGTCCAGATCCTGGCGGACCCAATCAGCGCGGCCCTCGGTCCTCCGCCCCTGACGGGCCTGGCCACGATCGATCCCGGCGCCGCCGTTCATGGCGCGGACGGGCAGGAGCGCTCGGTGCTCTGGACCCCCGCGGCGGTCGTTCGCGGCGCGCGCCATCGGCCCTGGCCGAGCCGCCAGGACCTGCGCCGGACGATCGACGCCACGGTGGCGGCCCTGGCCAGCGACGCGGGCCCGATTGTCTGCGAGATTTCCGGCGGCCTCGACTCGGCGATCGTCGCCACCAGCCTGGCGGCCAGCGGTCTTGGCCCACAGCTGACCGTGAATTTCTACGGCGACCAGCCAGAAGCCGATGAGCGCGGTTACGCCCAGGCGGTGGCCGAGCGCATCGGCGCGCCCCTGCGCACGCTCCGGCGCGAACCGTTCGCGTTCGACGAGACGGTGCTGGCCGCCGCCGGCCAGGCGGCGCGACCAAACTTCAACGCCCTTGATCCTGGCTACGACGCGGGGCTGGTCGGGGCGCTGGAGGCAATCGACGCTCGGGCGCTGTTCACCGGCCACGGCGGCGACACGGTGTTTTATCAGGTGGCGGCCAGCGCCCTGGCCGCGGACCTGCTCGGCGGCGCGCCTTGCGAGGGATCGCGACGCGCGCGGCTGGAGGAGGTCGCGCGGCGAACGAGGCGGTCGATTTGGAGCCTGGCCTGGGAGGCGTTCAGCGGCCGTCCCTCGACGGTGTCGATCGAAGGCCAACTCTTGCGCCAGGAAGCCGAACGGATCCGGCGGGTGGGCCTGACCCATCCTTGGGTGGGCGGGCTAAGCAGCGTCACCCCGGCCAAGCGACAGCAGATCCGGGCGCTGGTCTCGAACCTCAACGCCCATGGCGCCACCGGTCGGGCCGAGCGCGCCCGTATCGTCCACCCCTTGCTGGCCCAGCCGGTGGTCGAGGCCTGCCTGGCGATCCCCGCGCCCATACTCAGCGCGGGGGAAGGCGAGCGTAGTTTCGCCCGCGAGGCGTTCGCCGACCGGTTGCCTCCATCGATCGTCGGGCGGCGCTCGAAGGGTGAAATCAGCGTCTTCCTCAATCGCAGCCTCGCGGCTAGCGCGCCGTTTCTGCGCGGCTTTCTGCTGGAAGGCCGTCTGGCGGCGCGGGGCCTGATCGACCGCGACGAACTGGCGGCCGCGCTCGAGCCCGAGGCCATCGTCTGGAAGGACGCCTCCCGCGATCTCCTCACCGCCGCGGCCCTGGAGGCCTGGGTCCGTCATTGGGAGGCGCGGATCGGCGAGGGGGAAGCCGCCGAGGGCGAGAGGGCCGCGGGGCGCGGGACGGCGGCGACCGGTCCCAGGACGTCGGCGAGGAAGGCGAACACCCGTTGA	MGYAALTYPGGLAAAAFDEMVEALIDAGWTLALRAFRLAVLTDGQAPAVSPLMGRGGVAGVLIGEAFDRRATLGGAVARAALDGLADIDPLEAGRHLIETAWGGYVGMWIGRAEAGPTLLRDPSGALEALAWRRDGVTVMSARPLTGRAGPADLAIDWPRIVQILADPISAALGPPPLTGLATIDPGAAVHGADGQERSVLWTPAAVVRGARHRPWPSRQDLRRTIDATVAALASDAGPIVCEISGGLDSAIVATSLAASGLGPQLTVNFYGDQPEADERGYAQAVAERIGAPLRTLRREPFAFDETVLAAAGQAARPNFNALDPGYDAGLVGALEAIDARALFTGHGGDTVFYQVAASALAADLLGGAPCEGSRRARLEEVARRTRRSIWSLAWEAFSGRPSTVSIEGQLLRQEAERIRRVGLTHPWVGGLSSVTPAKRQQIRALVSNLNAHGATGRAERARIVHPLLAQPVVEACLAIPAPILSAGEGERSFAREAFADRLPPSIVGRRSKGEISVFLNRSLAASAPFLRGFLLEGRLAARGLIDRDELAAALEPEAIVWKDASRDLLTAAALEAWVRHWEARIGEGEAAEGERAAGRGTAATGPRTSARKANTR	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRIGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	224.36	gnl|BL_ORD_ID|772|hsp_num:0	816		
BGC0000574.1|Caulosegnin_3 # 4187 # 4837 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000574.1|Caulosegnin_3 	4187	4837	-	Loose	500	25.7942	OXA-114a	29.27	3001609	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGACCTGTGGCTCAGCGCCGGCGTGTACGCGGTCATGATCGATGACGATGTCGTCTTCCTCGATGTCGCGACCAACGCCTATTTCTGTCTGCCCGCGGTCGGGTCGGTGCTGGCCCTAGAGGGACGGTCCTTGCGCGTCGCGGCGCGTGAGCTGGCCGAAGACCTGATCCAGGCGGGCCTGGCCAGCGCCGCCGCCGCGATCGAGCCGCCGCCGAGCACGCCAGCGCCCGTCCGCACGGCGCGGGCCGTGCTGGAGGCGCTGCCGGCCCGCGAACGCCCGCGCCCACGCCTGGCCCATTGGCGGCAAGCCATCATGGCGGGGCTCGCCAGCCGGGCCGCCGAGCGGCGTCCCTTCGCCCAGCGCCTGCCGCCGCCGTCCACCGGGGTCTCTCCGCCCGCCAGCGAAGGGCTGCTGGCGGACCTCGACGCCTTTCGGCGACTCCAGCCCTGGTTGCCCTTCGACGGCGCCTGTCTGTTTCGCAGCCAGATGCTGCGCGACTATCTCCTCGCCCTGGGCCACCGCGTCGACTGGATCTTCGGCGTGCGCACCTGGCCGTTTGGGGCGCACTGCTGGCTGCAGGCGGGCGATCTGGTGCTTGATGACGAGGCCGAACGGCTCATCGCCTATCACCCGATCATGGTGCGCTAG	MDLWLSAGVYAVMIDDDVVFLDVATNAYFCLPAVGSVLALEGRSLRVAARELAEDLIQAGLASAAAAIEPPPSTPAPVRTARAVLEALPARERPRPRLAHWRQAIMAGLASRAAERRPFAQRLPPPSTGVSPPASEGLLADLDAFRRLQPWLPFDGACLFRSQMLRDYLLALGHRVDWIFGVRTWPFGAHCWLQAGDLVLDDEAERLIAYHPIMVR	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP	78.55	gnl|BL_ORD_ID|1788|hsp_num:0	1892		
BGC0000574.1|Caulosegnin_5 # 5340 # 5468 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.674	BGC0000574.1|Caulosegnin_5 	5340	5468	-	Loose	600	20.4014	MexC	54.17	3000800	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCAAGAAGAACGCCACCCAAGCCCCGCGTCTCGTGCGCGTCGGCGACGCCCATCGCCTGACGCAAGGCGCGTTCGTCGGCCAGCCCGAAGCGGTCAATCCGCTCGGCCGCGAAATCCAAGGCTGA	MTKKNATQAPRLVRVGDAHRLTQGAFVGQPEAVNPLGREIQG	MADLRAIGRIGALAMAIALAGCGPAEERQEAAEMVLPVEVLTVQAEPLALSSELPGRIEPVRVAEVRARVAGIVVRKRFEEGADVKAGDLLFQIDPAPLKAAVSRAEGELARNRAVLFEAQARVRRYEPLVKIQAVSQQDFDTATADLRSAEAATRSAQADLETARLNLGYASVTAPISGRIGRALVTEGALVGQGEATLMARIQQLDPIYADFTQTAAEALRLRDALKKGTLAAGDSQALTLRVEGTPYERQGALQFADVAVDRGTGQIALRGKFANPDGVLLPGMYVRVRTPQGIDNQAILVPQRAVHRSSDGSAQVMVVGADERAESRSVGTGVMQGSRWQITEGLEPGDRVIVGGLAAVQPGVKIVPKPDGAQAQAQSPAPQQ	10.85	gnl|BL_ORD_ID|765|hsp_num:0	805		
BGC0000574.1|Caulosegnin_6 # 5541 # 6137 # -1 # ID=1_6;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000574.1|Caulosegnin_6 	5541	6137	-	Loose	2000	25.7942	adeJ	35.29	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGCCCACGGCTGGGAGCCCGCGCTGGTGCGAGATCGCGATCCATTCGACCGAACCCTAGAGACGCTGCGCCAGCGCTTGACGCGGGCCGGTCCCTTGCAGGGCGCGGCCCTGCCGATCAGCGGCCTGGCCGAGGAACTGGGCGTGAGCCCAACCCCGGTTCGCGAGGTCTTGGCGCGCCTGGCCGGGGAGGGGCTGATCGCGCGCACGCCGCAGGGCTACGCGGCGCTGCTGCTTGATCCGGCCGGTCTCGCCGAGCTCTATGACCTGGCCAGCGTCCTGGTCGCCGCGGCCGTGCAGTCTGGCGCCCAGGCTGGCGACGGCTTTGATCTGGCCGATCCATTGTCTAGCGCCCAGGCCGCGCCCAATCGCGCCCTGGCGCAAGCCTGCGCGCGCGTCCAGGCCCAGTTGGCCCCGCTGGCCCGGGCCGAGGCCGAAGTCTTCGGCGCGGGGAGCGGCGGCGTCGCGGGCGATGATTGGGCCGATCGCAAGGCCTTGCTGCGCGCCGTGCGTCGCCACTACGCCCGCCGCGCGGCCCAGAGCGGCCGCATCCTCGCCGTGGCTCTGGGCCTGCTCAAATCTCCCCGAATATAG	MTAHGWEPALVRDRDPFDRTLETLRQRLTRAGPLQGAALPISGLAEELGVSPTPVREVLARLAGEGLIARTPQGYAALLLDPAGLAELYDLASVLVAAAVQSGAQAGDGFDLADPLSSAQAAPNRALAQACARVQAQLAPLARAEAEVFGAGSGGVAGDDWADRKALLRAVRRHYARRAAQSGRILAVALGLLKSPRI	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	18.71	gnl|BL_ORD_ID|589|hsp_num:0	630		
